Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
British Journal of Pharmacology
|
April 20, 2001
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice
D W Hay, S A Douglas, Z Ao, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist
T J Torphy, I Faiferman, J G Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist
E H Ohlstein, P Nambi, A Lago, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig
D C Underwood, S Bochnowicz, R R Osborn, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1989
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes
T J Torphy, J F Newton, M A Wasserman, et al.
Molecular Pharmacology
|
August 23, 2000
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin
H M Sarau, J L Mooney, D B Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1987
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways
D W Hay, R M Muccitelli, S S Tucker, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework
G A Giardina, H M Sarau, C Farina, et al.
Journal of Cardiovascular Pharmacology
|
November 15, 2000
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice
D E Griswold, S A Douglas, L D Martin, et al.
Molecular Pharmacology
|
September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation
D E Griswold, S A Douglas, L D Martin, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
British Journal of Pharmacology
|
April 20, 2001
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice
D W Hay, S A Douglas, Z Ao, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist
T J Torphy, I Faiferman, J G Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist
E H Ohlstein, P Nambi, A Lago, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig
D C Underwood, S Bochnowicz, R R Osborn, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1989
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes
T J Torphy, J F Newton, M A Wasserman, et al.
Molecular Pharmacology
|
August 23, 2000
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin
H M Sarau, J L Mooney, D B Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1987
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways
D W Hay, R M Muccitelli, S S Tucker, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework
G A Giardina, H M Sarau, C Farina, et al.
Journal of Cardiovascular Pharmacology
|
November 15, 2000
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice
D E Griswold, S A Douglas, L D Martin, et al.
Molecular Pharmacology
|
September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation
D E Griswold, S A Douglas, L D Martin, et al.
Page
of 12